Yejin Jang

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Design, Synthesis, and Antiviral Activity of 8‑Aza Fluoroneplanocin Derivatives Targeting SAH Hydrolase and Viral RdRp.

Design, Synthesis, and Antiviral Activity of 8‑Aza Fluoroneplanocin Derivatives Targeting SAH Hydrolase and Viral RdRp.

Journal: ACS medicinal chemistry letters

Published: July 29, 2025

A Modular Vaccine Platform Against SARS-CoV-2 Based on Self-Assembled Protein Nanoparticles.

A Modular Vaccine Platform Against SARS-CoV-2 Based on Self-Assembled Protein Nanoparticles.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 16, 2025

Identification of 4'-Thiouridine as an Orally Available Antiviral Agent Targeting Both RdRp and NiRAN Functions of SARS-CoV-2 Nsp12.

Identification of 4'-Thiouridine as an Orally Available Antiviral Agent Targeting Both RdRp and NiRAN Functions of SARS-CoV-2 Nsp12.

Journal: Journal of medicinal chemistry

Published: June 13, 2025

Inhibition of endocytic uptake of severe acute respiratory syndrome coronavirus 2 and endo-lysosomal acidification by diphenoxylate.

Inhibition of endocytic uptake of severe acute respiratory syndrome coronavirus 2 and endo-lysosomal acidification by diphenoxylate.

Journal: Antimicrobial agents and chemotherapy

Published: May 14, 2024

A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents.

A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents.

Journal: ACS central science

Published: April 05, 2024

A dual inhibitor of PIP5K1C and PIKfyve prevents SARS-CoV-2 entry into cells.

A dual inhibitor of PIP5K1C and PIKfyve prevents SARS-CoV-2 entry into cells.

Journal: Experimental & molecular medicine

Published: December 14, 2023

Discovery of antiviral SARS-CoV-2 main protease inhibitors by structure-guided hit-to-lead optimization of carmofur.

Discovery of antiviral SARS-CoV-2 main protease inhibitors by structure-guided hit-to-lead optimization of carmofur.

Journal: European journal of medicinal chemistry

Published: June 13, 2023

Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2.

Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2.

Journal: ACS infectious diseases

Published: March 13, 2023

Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice.

Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice.

Journal: Antiviral research

Published: February 02, 2023

Synthesis and biological evaluation of new β-D-N4-hydroxycytidine analogs against SARS-CoV-2, influenza viruses and DENV-2.

Synthesis and biological evaluation of new β-D-N4-hydroxycytidine analogs against SARS-CoV-2, influenza viruses and DENV-2.

Journal: Bioorganic & medicinal chemistry letters

Published: December 12, 2022

Severe acute respiratory syndrome coronavirus 2 variants-Possibility of universal vaccine design: A review.

Severe acute respiratory syndrome coronavirus 2 variants-Possibility of universal vaccine design: A review.

Journal: Computational and structural biotechnology journal

Published: March 28, 2022

Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents.

Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents.

Journal: Drug discovery today

Published: December 19, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026